Positive Clinical Trial Results Spur American Gene Technologies® to Launch Addimmune™, a Company with One Focus: Cure HIV

When Jeff Galvin founded American Gene Technologies in 2008, he envisioned a future where gene therapy could be used to write disease out of the genetic code. Today, on June 9, 2023, that future just got a lot closer with three major announcements: The company’s HIV gene therapy, AGT103-T, has yielded encouraging data through… Positive Clinical Trial Results Spur American Gene Technologies® to Launch Addimmune™, a Company with One Focus: Cure HIV appeared first on American Gene Technologies .